Author

Pavitra Kannan

Karolinska InstitutetORCID 0000-0002-9170-6062Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Pavitra Kannan1 paper

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:zebrafish· 1

Frequent Co-Authors

David Philip LaneiD· 1 shared Dilraj LamaiD· 1 shared Filip MihaličiD· 1 shared Jason N. BermaniD· 1 shared Kim KobariD· 1 shared Lars BräutigamiD· 1 shared Martin KrkoškaiD· 1 shared Sania Kheder· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

David Philip LaneORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A stapled peptide inhibitor of MDM2 enables pharmacological activation of p53 in zebrafish

Sania Kheder, Martin Krkoška, Filip Mihalič, Kim Kobar, Zdeněk Andrysík, Lars Bräutigam, Susanne Lindström, Jason N. Berman, David Philip Lane, Dilraj Lama, Pavitra Kannan

The paper demonstrates that sulanemadlin, a stapled peptide inhibitor of MDM2, specifically activates p53 in zebrafish without inducing apoptosis, enabling direct in vivo studies of p53 regulation.

bioRxiv · Mar 30, 2026 · PreprintPharmacology & Toxicology